Deyu Kong

Statistics

Publications

Citations

616

H-Index

Active since

1998

Affiliations

First Affiliated Hospital of Kunming Medical University(Current)

Kunming Medical University

Shanghai Jiao Tong University

Chinese Academy of Sciences

East China Normal University

Deyu Kong is an author at First Affiliated Hospital of Kunming Medical University specializing in life sciences, molecular biology, and drug discovery.

ORCID

Publications per year

1998–2024

Publications

Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity

Zhengnan Shen, Kiira Ratia, Laura Cooper et al. · Journal of Medicinal Chemistry · 2021 · 211 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +16

Potent, Novel SARS-CoV-2 PLpro Inhibitors Block Viral Replication in Monkey and Human Cell Cultures

Zhengnan Shen, Kiira Ratia, Laura Cooper et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 40 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +17

Immunomodulation of human CD19+CD25high regulatory B cells via Th17/Foxp3 regulatory T cells and Th1/Th2 cytokines

Min Hee Hong, Yun Liao, Jin Liang et al. · Human Immunology · 2019 · 33 citations

Life Sciences, Cell Biology, Immunology +16

Optimization of P2Y<sub>12</sub> Antagonist Ethyl 6-(4-((Benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283) Led to the Discovery of an Oral Antiplatelet Agent with Improved Druglike Properties

Deyu Kong, Tao Xue, Bin Guo et al. · Journal of Medicinal Chemistry · 2019 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma

Yuanyuan Xu, Min Hee Hong, Deyu Kong et al. · BMC Genomics · 2022 · 31 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 19